Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Koshaheiisan-ka-shakuyaku extract is a traditional Japanese Kampo medicine formulated to treat various gastrointestinal disorders characterized by abdominal pain, dyspepsia, and fullness. It is a modification of the classical Heiisan (Ping Wei San) formula, which is designed to resolve dampness and harmonize the stomach. The addition of 'Kosha' (Cyperus rotundus and Amomum villosum) enhances the formula's ability to promote the movement of Qi and relieve stagnation, while the addition of 'Shakuyaku' (Paeonia lactiflora) provides potent antispasmodic and analgesic effects. Pharmacologically, the extract contains active compounds such as paeoniflorin, which modulates smooth muscle contraction, and glycyrrhizin, which exerts anti-inflammatory effects. It is primarily indicated for patients with weak digestive systems who experience bloating, loss of appetite, and cramping.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on koshaheiisan-ka-shakuyaku extract.